Related Experiment Video
Updated: Jul 17, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Maintenance therapy for multiple myeloma with particular emphasis on thalidomide
1Klinik für Hämatologie/Onkologie, St. Marien-Hospital Hamm, Germany. heinz.duerk@marienhospital-hamm.de
Onkologie
|January 5, 2007
Summary
Thalidomide shows promise as a maintenance therapy for multiple myeloma, significantly improving overall survival after autologous stem cell transplantation. Dose adjustment is key to managing side effects, enhancing treatment tolerability.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Current multiple myeloma maintenance therapy often involves prednisone, dexamethasone, and interferon-a.
- New therapeutic strategies are emerging for multiple myeloma maintenance therapy.
Purpose of the Study:
- To evaluate thalidomide as a maintenance therapy option for multiple myeloma.
- To assess the efficacy and safety of thalidomide in improving patient outcomes.
Main Methods:
- Review of studies investigating thalidomide for maintenance therapy in multiple myeloma.
- Analysis of data from conventional chemotherapy and autologous stem cell transplantation contexts.
- Examination of phase III study results for overall survival improvements.
Main Results:
- Thalidomide demonstrated an upgrade in response in 22-73% of patients.
- Significant prolongation of progression-free survival was observed.
- A recent phase III study reported a significant improvement in overall survival with thalidomide maintenance therapy.
Conclusions:
- Thalidomide is a well-documented option for maintenance therapy post-autologous stem cell transplantation in multiple myeloma.
- Individual dose adjustment of thalidomide is recommended to manage adverse effects like neuropathy and bradycardia.
- Intermittent administration may further improve thalidomide tolerability.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...